| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/19/1992 | CA1301153C 3-(1h-tetrazol-5-yl)thieno(2,3-d)pyrimidin-4(3h)-ones |
| 05/19/1992 | CA1301151C 3,3-disubstituted indolines |
| 05/19/1992 | CA1301066C Anti-tumour substance and process for producing the same |
| 05/19/1992 | CA1301063C Biologically degradable superparamagnetic materials for use in clinicalapplications |
| 05/18/1992 | CA2055689A1 Substituted anilides |
| 05/18/1992 | CA2055536A1 Antacid preparation having a prolonged gastric residence time |
| 05/17/1992 | WO1992008462A1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-thion-1,1-dioxides as antiviral medicaments |
| 05/17/1992 | WO1992008455A1 Avermectins and milbemycins to treat parasitic in dogs |
| 05/17/1992 | WO1992008373A1 Semduramicin premix |
| 05/17/1992 | CA2096239A1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-thione 1,1-dioxides as antiviral medicaments |
| 05/17/1992 | CA2055680A1 Tricyclic compounds |
| 05/17/1992 | CA2055636A1 Substituted azoles, process for their preparation, agents containing them and their use |
| 05/17/1992 | CA2055630A1 Naphthalene derivatives |
| 05/16/1992 | WO1992008724A1 New heterocyclic compounds as antagonists of excitatory amino acid receptors, processes for their preparation and their use |
| 05/16/1992 | WO1992008709A1 Meta-substituted phenyl alanine derivatives |
| 05/16/1992 | WO1992008453A1 Hydroxamic acids for preventing reperfusion injury |
| 05/16/1992 | CA2095606A1 Hydroxamic acids for preventing reperfusion injury |
| 05/16/1992 | CA2095224A1 Heterocyclic compounds as antagonists of excitatory amino acid receptors, processes for their preparation and their use |
| 05/16/1992 | CA2073776A1 Meta-substituted phenyl alanine derivatives |
| 05/16/1992 | CA2055683A1 Complexes containing s(+) phenyl alkane acids and .alpha.-amino acids |
| 05/16/1992 | CA2055682A1 Complexes containing s(+) phenyl alkane acids and -hydroxyalkane acids |
| 05/16/1992 | CA2055681A1 Complexes containing s(+) phenyl alkane acids and amino sugars |
| 05/16/1992 | CA2055578A1 Aqueous gel with retinoic acid and hydroxypropyl-.beta.-cyclodextrine, and use thereof in human medicine and cosmetic applications |
| 05/15/1992 | WO1992008718A1 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents |
| 05/15/1992 | WO1992008705A1 5-fluoro-2,4,6-pyrimidinetriamine compounds |
| 05/15/1992 | WO1992008461A1 Specific inhibition of dihydrofolate reductase and compounds therefor |
| 05/15/1992 | CA2095518A1 Specific inhibition of dihydrofolate reductase and compounds therefor |
| 05/15/1992 | CA2094246A1 4-(1,2-benzisoxazolyl) piperidine antipsychotic agents |
| 05/15/1992 | CA2092811A1 5-fluoro-2,4,6-pyrimidinetriamine compounds |
| 05/15/1992 | CA2055334A1 Semisynthetic diastereomerically pure n-glycidylanthracyclines, a process for the steroselective preparation thereof and the use thereof as cytostatics |
| 05/15/1992 | CA2055326A1 N-benzoylproline derivatives, a process for their preparation and pharmaceutical compositions holding same |
| 05/15/1992 | CA2055325A1 Novel imidazole derivatives, process for preparing them and pharmaceutical compositions containing them |
| 05/15/1992 | CA2055225A1 Compounds, pharmaceutical compositions containing them and process for preparing same |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007920A1 Improved processes for the manufacture of enriched pitches and carbon fibers |
| 05/14/1992 | WO1992007847A1 Fused pyrazine derivative |
| 05/14/1992 | WO1992007838A1 Thiazolidine dione derivatives |
| 05/14/1992 | WO1992007832A2 Substituted piperazines as central nervous system agents |
| 05/14/1992 | WO1992007831A1 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 05/14/1992 | WO1992007826A1 Oxysulfonyl carbamates |
| 05/14/1992 | WO1992007819A1 Tri(lower alkoxy)benzene derivative |
| 05/14/1992 | WO1992007589A1 Transdermal contraceptive formulations, methods and devices |
| 05/14/1992 | WO1992007586A1 Topical composition with retinoid penetration enhancer |
| 05/14/1992 | WO1992007575A1 Antimicrobial composition |
| 05/14/1992 | WO1992007572A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | WO1992007570A1 Agents for the treatment of diseases caused by parasitic protozoa and neoplastic diseases |
| 05/14/1992 | WO1992007569A1 Alteration of rate and character of hair growth |
| 05/14/1992 | WO1992007568A1 η-TURN PEPTIDOMIMETICS AS FIBRINOGEN ANTAGONISTS |
| 05/14/1992 | WO1992007566A2 Antifungal activity of and prevention of drug induced nephrotoxicity by methylxanthine analogues |
| 05/14/1992 | WO1992007565A1 Sampangine and derivatives useful as antifungal agents |
| 05/14/1992 | WO1992007564A2 Method of treating demyelinating disease |
| 05/14/1992 | WO1992007563A1 Treatment of ocular hypertension with class i calcium channel blocking agents |
| 05/14/1992 | WO1992007562A1 Controlling glutamine/glutamate related neuronal injury |
| 05/14/1992 | WO1992007560A1 Biguanides and derivatives thereof as inhibitors of advanced glycosylation of a target protein |
| 05/14/1992 | WO1992007559A1 Dextromethorphan antitussive compositions |
| 05/14/1992 | WO1992007549A1 Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic |
| 05/14/1992 | WO1992007544A1 External preparation for skin |
| 05/14/1992 | WO1992007465A1 Microbiocidal combinations of materials and their use |
| 05/14/1992 | WO1992004024A3 Toxic agent protective compounds, compositions and method |
| 05/14/1992 | WO1992004014A3 Regulation of neoplastic cell proliferation via a novel 5ht1a receptor |
| 05/14/1992 | WO1992001718A3 Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/1992 | WO1991016903A3 Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation |
| 05/14/1992 | DE4036140A1 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel 9-halo-11ß-hydroxy-prostaglandin derivatives, to processes for their preparation and their use as medicaments |
| 05/14/1992 | DE4035809A1 Verwendung von thiazoloisoindolinon-derivaten als antivirale arzneimittel Use of thiazoloisoindolinon derivatives as antiviral drug |
| 05/14/1992 | DE4035682A1 Lokalanaesthetikum Local anesthetic |
| 05/14/1992 | CA2095330A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | CA2094911A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | CA2094724A1 Tri(lower alkoxy) benzene derivatives |
| 05/14/1992 | CA2055094A1 Cholecystokinin antagonist |
| 05/14/1992 | CA2055024A1 N-phenyl piperidinylcamphorsulfonyl oxytocin antagonists |
| 05/14/1992 | CA2054958A1 Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof |
| 05/13/1992 | EP0485232A1 Neovascularisation inhibitors |
| 05/13/1992 | EP0485219A2 Medicaments for preventing and treating circulatory organ diseases containing spiro-3-heteroazolidine compounds |
| 05/13/1992 | EP0485217A2 Hydantoin derivatives, and their use in preventing and treating diabetic complications and circulatory organ diseases |
| 05/13/1992 | EP0485173A2 Esters and amides of substituted fused ring phenyl acetic acids |
| 05/13/1992 | EP0485172A2 Esters and amides of substituted indenyl acetic acids |
| 05/13/1992 | EP0485170A1 Enhanced flavors using menthone ketals |
| 05/13/1992 | EP0485158A2 Esters and amides of substituted phenyl acetic acids |
| 05/13/1992 | EP0485157A2 Esters and amides of substituted pyrrole acetic acids |
| 05/13/1992 | EP0485111A2 The use of lipoxygenase and cyclooxygenase inhibitors as synergistic agents |
| 05/13/1992 | EP0485045A2 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them |
| 05/13/1992 | EP0485026A2 Antimanic phenoxymethylene bisphosphonate derivatives |
| 05/13/1992 | EP0484988A1 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives and pharmaceutical composition containing the same |
| 05/13/1992 | EP0484966A2 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation |
| 05/13/1992 | EP0484949A2 Ester inhibitors |
| 05/13/1992 | EP0484936A1 Suspensions containing tricyclic compounds |
| 05/13/1992 | EP0484881A2 Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
| 05/13/1992 | EP0484870A2 Prodrugs for beta-lactamase and uses thereof |
| 05/13/1992 | EP0484856A2 Dynemicin C antitumor antibiotic |
| 05/13/1992 | EP0484785A2 Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses |
| 05/13/1992 | EP0484660A1 Novel 5-(Phenoxyalcanoylamino)-uraciles, methodes for preparing them and their use as medicaments |
| 05/13/1992 | EP0484596A1 Organotin compounds and anti-tumor compositions containing them |
| 05/13/1992 | EP0484581A1 Use of thromboxane A2 receptor antagonists for preventing degenerative processes in penile tissues |
| 05/13/1992 | EP0484573A1 4- and 6-Carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments |
| 05/13/1992 | EP0484497A1 Febarbamate for the treatment of cranial nervous disorders and encephalic circulation and metabolism disorders |
| 05/13/1992 | EP0484486A1 Foodstuff with prophylactic and/or curative effect and process for making it. |
| 05/13/1992 | EP0484437A1 Renal-selective prodrugs for the treatment of hypertension |
| 05/13/1992 | EP0484387A1 Biodegradable system for regenerating the periodontium. |
| 05/13/1992 | EP0429645A4 Reducing the spread of infection by blood handling equipment |
| 05/13/1992 | EP0227844B1 Antiviral drug |